The Marque The Marque
The Marque
About The Marque Profiles Contact

Brendan Kennedy

President & CEO

Tilray

Seattle, WA, USA

Brendan Kennedy
Paul Kempe
City & Provincial Properties Plc
Kerry Kennedy
RFK / Robert F. Kennedy Human Rights

Biography

Brendan Kennedy is Chief Executive Officer of Tilray, a global leader in medical cannabis industry. Tilray was the first GMP-certified medical cannabis producer to supply products to patients, researchers, and the medical community, earning itself the recognition of being a pioneer in cannabis research, cultivation, processing, and distribution

In 2011, along with Michael Blue and Christian Groh, Brendan Co-founded Privateer Holdings, the world’s first private equity firm to invest exclusively in legal cannabis. At Privateer, Brendan used his background of entrepreneurship and hands-on business experience to successfully lead the development of new and existing companies, origination and distribution of products, and management of operations. While he was at the helm of Privateer, the firm raised over $200 million to build a global portfolio of leading cannabis businesses.

Brendan has always had a voracious appetite for information and keen insight into technology and growth industries, both of which led him to the forefront of consultation and solutions for the venture-backed business community. Prior to co-founding Privateer, he served as the Chief Operating Officer of Silicon Valley Bank Analytics from 2010 to 2011 and Managing Director from 2006 to 2010. In these roles, he managed an international team that rendered valuation opinions for emerging growth technology, life science and venture capital companies.

Brendan earned a BA from the University of California, Berkeley, an MS in Engineering from the University of Washington, and an MBA from the Yale School of Management.

Brendan’s Newsfeed

Business Wire
Tilray Announces Agreement with Grow Pharma to Import and Distribute Medical Cannabis Products in UK

Brendan Kennedy, Tilray’s Chief Executive Officer, said, “This partnership with Grow Pharma provides patients in need access to a sustained supply of GMP-certified, high-quality medical cannabis and is an important step in improving access in the UK. Tilray will continue to advocate for reasonable patient access to medical cannabis in Europe and countries around the world.”

The Motley Fool
Tilray and Aphria to Merge, Creating Largest Marijauna Company in the World

A blockbuster merger in the cannabis industry was announced Wednesday morning. Canadian peers Tilray and Aphria are combining to make the world's largest marijuana company... The merged company will retain the Tilray name, with the stock keeping its current ticker symbol. It will be led by Aphria's CEO Irwin Simon, with seven of the nine seats on the new business's board of directors going to present Aphria directors. The remaining two directors will be from Tilray, including that company's CEO Brendan Kennedy.

View allHide

Brendan’s Background

Tilray
President & CEO
Aug 2013 - Present
Nanaimo, CA
Tilray is a global leader in medical cannabis research and production dedicated to providing safe, consistent and reliable therapy to patients. It is the only GMP certified medical cannabis producer currently supplying products to thousands of patients, physicians, pharmacies, hospitals, governments and researchers in Australia, Canada, the European Union and the Americas.
Privateer Holdings, Inc.
Executive Chairman
Jul 2018 - Dec 2020
Seattle, WA, USA
Privateer Holdings is a private equity firm that is actively shaping the remarkably promising cannabis marketplace through the development of strategic acquisitions and investments. Through a combination of acquisitions, investments, and incubation, Privateer is focused on building a portfolio of global brands that will lead, legitimize, and define the future of cannabis.
View allHide

Current Board Positions

Tilray
Board of Directors
Jan 2018 - Present
Nanaimo, CA
Tilray is a global leader in medical cannabis research and production dedicated to providing safe, consistent and reliable therapy to patients. It is the only GMP certified medical cannabis producer currently supplying products to thousands of patients, physicians, pharmacies, hospitals, governments and researchers in Australia, Canada, the European Union and the Americas.

Previous Board Positions

Privateer Holdings, Inc.
Board of Directors
2011 - 2019
Seattle, WA, USA
Privateer Holdings is a private equity firm that is actively shaping the remarkably promising cannabis marketplace through the development of strategic acquisitions and investments. Through a combination of acquisitions, investments, and incubation, Privateer is focused on building a portfolio of global brands that will lead, legitimize, and define the future of cannabis.

Media

Closing Bell: Aphria and Tilray merge in an all-stock deal as demand for cannabis grows
Interview
Dec 2020
New York, NY, USA
Aphria and Tilray are merging in an all-stock deal to form the largest cannabis company by revenue. Aphria CEO Irwin Simon and Tilray CEO Brendan Kennedy join ‘Closing Bell’ to talk about the growth of consumer demand for cannabis in the U.S.
The Wall Street Journal
"A CEO Tries to Navigate the Legal Cannabis Sector’s Bad Trip"
Mar 2020
New York, NY, USA
Brendan Kennedy, CEO of Privateer Holdings, Inc. and CEO of Tilray, talks with Chris Kornelis about the burgeoning legal marijuana industry and the opportunities and challenges it poses.
View allHide

Brendan’s Education

University of Washington
MS Engineering
1994 - 1995
View allHide